Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome

Clinical trial NCT00452192 · COMPLETED

Trial details

NCT number: NCT00452192
Sponsor: University of Erlangen-Nürnberg Medical School
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metabolic Syndrome

Start date: 2006-11-01
Primary completion: 2009-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.